Silver Book Fact

Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient. 

Ubel P, Berry S, Nadler E, Bell C, et al. In a Survey, Marked Inconsistency in How Oncologists Judged Value of High-Cost Cancer Drugs in Relation to Gains in Survival. Health Aff. 2012; 31(4): 709-717. http://content.healthaffairs.org/content/31/4/709.abstract

Reference

Title
In a Survey, Marked Inconsistency in How Oncologists Judged Value of High-Cost Cancer Drugs in Relation to Gains in Survival
Publication
Health Aff
Publisher
Project HOPE
Publication Date
2012
Authors
Ubel P, Berry S, Nadler E, Bell C, et al
Volume & Issue
Volume 31, Issue 4
Pages
709-717
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.  
  • An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer…  
  • Because of advances in treatment, the 5-year survival rate for people with actue lymphocytic leukemia has increased from 38% in 1974-1976 to 65% in 1995-2001.  
  • Image-guided breast biopsy takes about 1/5 the of a surgical biopsy, reduces complications and allows women to commence daily activities in 1/2 the time that it takes after open surgery.…  
  • Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung…